Government Going After Doctor Kickbacks

In the history of drug litigation, one fact that clearly emerged is that companies paid doctors a lot of money or provided a great deal of free samples and gifts to promote their drugs.  Many times the doctors were “thought leaders” or provided stipends to make “academic presentations” to doctors with the real purpose of [...]

January 15th, 2014|Drug and Medical Device Litigation|0 Comments

GSK to Stop Paying Doctors for Promoting Its Products

In the history of drug litigation, one fact that clearly emerged is that companies paid doctors a lot of money or provided a great deal of free samples and gifts to promote their drugs.  Also, sales reps had sales targets for specific doctors and were often given bonuses based on prescriptions from doctors in their [...]

December 19th, 2013|Drug and Medical Device Litigation|0 Comments

GSK Continues to Pay for Avandia Claims

Problems with Avandia continue to haunt GSK. Previously, GSK has settled thousands of claims over Avandia while claiming there is nothing wrong with the onetime diabetes wonder drug.  And now confronted with allegations brought by the State of Utah the drug giant defrauded the state’s Medicaid program through allegedly false and misleading marketing of Avandia, [...]

December 10th, 2013|Avandia Diabetes Drug, Drug and Medical Device Litigation|0 Comments

Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn.  Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]

Why Are Drugs More Expensive in U.S. than in Other Countries?

Across America and throughout the world people with the same condition take the same drugs.  However, the prices vary greatly.  Take asthma, which affects 40 million Americans and countless millions throughout the world and is estimated by the Center for Disease Control and prevention to cost Americans $56 billion annually. One of the leading asthma [...]

October 14th, 2013|Drug and Medical Device Litigation, General Interest|0 Comments